Edi Easterndrug India Private Limited
About Edi Easterndrug India Private Limited
Data last updated:
Edi Easterndrug India Private Limited is a private limited company based in Bhubaneswar, Odisha, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 November 2022.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U24239OR2022PTC041171. Its GSTIN is 21AAHCE3211F1ZE (Odisha).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Harshvardhan Bhardwaj and Aman Bhardwaj.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.119/E Zone – A Sector – A Mancheswar Industrial Estate Mancheswar, Bhubaneswar, Odisha, India – 751010.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.6 Cr, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹3.77 Lakh (net margin 2.4%) and EBITDA of ₹16.7 Lakh (EBITDA margin 10.5%).
The company has about 24 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹50 Lakh on record.
Company details
Contact details
Edi Easterndrug India Private Limited's registered office is in Bhubaneswar, Odisha. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No.119/E Zone – A Sector – A Mancheswar Industrial Estate Mancheswar, Bhubaneswar, Odisha, India – 751010
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Edi Easterndrug India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Edi Easterndrug India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Edi Easterndrug India Private Limited, buy the company report.
Financials of Edi Easterndrug India Private Limited
FY 2025 filings availableEdi Easterndrug India Private Limited reported revenue of ₹1.6 Cr (down 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 3% in the latest year. EBITDA rose 18% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹16.7 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹3.77 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 10.5% | ||
| Net Profit Margin | 2.4% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Edi Easterndrug India Private Limited, buy the company report.
Board of directors of Edi Easterndrug India Private Limited
Edi Easterndrug India has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harshvardhan Bhardwaj | Director | 14 Nov 2022 | 3 Years 11 Months | Current |
| Aman Bhardwaj | Additional Director | 08 Dec 2022 | 3 Years 10 Months | Current |
Peer comparison
Edi Easterndrug India Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Powder Spray Industries Private Limited | ₹1.6 Cr (FY 2025) | 0.0% | Jodhpur, Rajasthan, India | |||
| Anupam Talc Private Limited | ₹1.6 Cr (FY 2025) | -10.0% | Udaipur, Rajasthan, India | |||
| Ce Organics India Private Limited | ₹1.6 Cr (FY 2024) | 483.0% | Bengaluru, Karnataka, India | |||
| Royalkaveri Gases Private Limited | ₹1.6 Cr (FY 2024) | 16.0% | Anekal, Karnataka, India | |||
| Innovac Bioscience Private Limited | ₹1.6 Cr (FY 2025) | -12.0% | Vadodara, Gujarat, India | |||
| Edi Easterndrug India Private Limitedthis company | ₹1.6 Cr (FY 2025) | ₹3.77 Lakh | 2.4% | -3.0% | Bhubaneswar, Odisha, India | |
| Krew Instruments Private Limited | ₹1.6 Cr (FY 2024) | -44.0% | Kalyan, Maharashtra, India | |||
| Redevelop Biotech India Private Limited | ₹1.6 Cr (FY 2025) | -10.0% | Rudrapur, Uttarakhand, India | |||
| Weizur India Private Limited | ₹1.6 Cr (FY 2024) | 66.0% | Anand, Gujarat, India | |||
| SGMR Pharmaceuiticals Private Limited | ₹1.6 Cr (FY 2025) | -35.0% | Hyderabad, Telangana, India | |||
| Bionic Properties Private Limited | ₹1.6 Cr (FY 2024) | 14.0% | Bhubaneswar, Odisha, India |
To see the full peer comparison of Edi Easterndrug India Private Limited, buy the company report.
Auditor
Edi Easterndrug India Private Limited is audited by P.K.NAYAK& CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P.K.NAYAK& CO. | FY 2023 | 318155E |
Shareholding
The shareholding of Edi Easterndrug India Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Edi Easterndrug India Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Dec 2025 | 101206318 | Others | ₹50 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Edi Easterndrug India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Edi Easterndrug India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Edi Easterndrug India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21AAHCE3211F1ZE | Odisha | Active | 01 Apr 2023 |
To see the full GST registrations and return filing status of Edi Easterndrug India Private Limited, buy the company report.
Recent activity
Edi Easterndrug India Private Limited has 4 board changes on record since 2022: 3 appointments and 1 cessation. The latest: Prem Shankar Pathak ceased to be Director on 22 Nov 2025.
Frequently asked questions
Edi Easterndrug India is an active private limited company based in Bhubaneswar, Odisha, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 November 2022 (4+ years old) and is registered under CIN U24239OR2022PTC041171.
Edi Easterndrug India has 2 current directors:
- Harshvardhan Bhardwaj - Director
- Aman Bhardwaj - Additional Director
The latest financial statements of Edi Easterndrug India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Edi Easterndrug India is 21AAHCE3211F1ZE, registered in Odisha.
The CIN (Corporate Identification Number) of Edi Easterndrug India is U24239OR2022PTC041171. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Edi Easterndrug India was incorporated on 14 November 2022, making it 4+ years old. It is registered with the Registrar of Companies, Cuttack.
The peers of Edi Easterndrug India by revenue are Powder Spray Industries Private Limited, Anupam Talc Private Limited, Ce Organics India Private Limited, Royalkaveri Gases Private Limited, Innovac Bioscience Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Prem Shankar Pathak ceased to be Director on 22 Nov 2025. Aman Bhardwaj was appointed as Additional Director on 08 Dec 2022. Harshvardhan Bhardwaj was appointed as Director on 14 Nov 2022. Edi Easterndrug India has 4 board changes on record in total.
The registered office of Edi Easterndrug India is at Plot No.119E Zone – A Sector – A Mancheswar Industrial Estate Mancheswar, Bhubaneswar, Odisha, India – 751010.
Edi Easterndrug India operates in the pharma industry, in the drug formulation and development segment.
Edi Easterndrug India has open charges of ₹50 Lakh and no satisfied charges on record as per latest MCA filings.